Patrice P. Denefle
Chief Tech/Sci/R&D Officer en CENTOGENE N.V. .
Perfil
Patrice P.
Denefle is currently the Chief Scientific Officer at Centogene NV since 2021.
Prior to this, he held the same position at Genethon and 4P-Pharma.
He completed his undergraduate degree at Université De Lille.
Cargos activos de Patrice P. Denefle
| Empresas | Cargo | Inicio |
|---|---|---|
| CENTOGENE N.V. | Chief Tech/Sci/R&D Officer | 16/08/2021 |
Antiguos cargos conocidos de Patrice P. Denefle.
| Empresas | Cargo | Fin |
|---|---|---|
| 4P-Pharma | Chief Tech/Sci/R&D Officer | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | - |
Formación de Patrice P. Denefle.
| Université De Lille | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| Empresas privadas | 2 |
|---|---|
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
| 4P-Pharma | Commercial Services |
- Bolsa de valores
- Insiders
- Patrice P. Denefle
